创伤性脑损伤中长压力反应性指数的关键阈值及颅内压监测方法的影响
本研究纳入瑞典卡罗林斯卡大学医院435例中重度创伤性脑损伤患者,按1年格拉斯哥结局量表分为存活/死亡和预后良好/不良,用Pearson卡方值确定与结局判别力最高的LPRx和ICP阈值。结果示10–120分钟窗口计算的LPRx行为相似,最大卡方值出现在LPRx约0.25–0.35处,兼顾生存与良好预后;前4天阈值与结局关联最强。基于EVD与IPD分段数据差异有限,LPRx均在0.3左右。作者认为低分辨率、低采样LPRx在PRx不可行时可作为其临床预后价值的替代,但需进一步研究。
要点
- 435例中重度TBI患者中,10–120分钟窗口计算的LPRx判别能力相似,最大卡方值集中在LPRx约0.25–0.35。
- LPRx阈值与结局的时间关系显示,入院前4天与1年生存及良好预后关联最强。
- 按颅内压监测方式分段,EVD与IPD获得的LPRx差异有限,均在0.3左右,预后判别能力相似。
- 作者认为LPRx可用低至10分钟逐分钟MAP和ICP采样计算,在PRx不可行时可作为其临床预后价值的替代。
- 作者指出该低分辨率低采样LPRx方法需进一步研究。
适用人群与场景
- 瑞典卡罗林斯卡大学医院纳入的435例中重度创伤性脑损伤患者。
- 按1年格拉斯哥结局量表分为存活 vs 死亡、预后良好 vs 不良。
诊断标准与关键阈值
- LPRx阈值:10–120分钟窗口计算的LPRx最大卡方值位于约0.25–0.35,对生存和良好预后均如此。
处置流程与药物剂量
- LPRx可用低至10分钟逐分钟MAP和ICP采样计算(原文结论)。
- LPRx可经EVD或IPD颅内压监测获得,两者预后判别能力相似(原文结论)。
研究设计与关键结果
- 观察性研究,纳入435例中重度TBI患者,按1年GOS分为存活/死亡和预后良好/不良,用Pearson卡方值确定LPRx和ICP的最佳判别阈值。
- 10–120分钟窗口计算的LPRx行为相似,最大卡方值位于LPRx约0.25–0.35,兼顾生存与良好预后。
- 时间关系分析显示前4天LPRx阈值与结局关联最强。
- 按EVD与IPD分段,两者差异有限,LPRx均在0.3左右。
证据类型、等级与局限
- 证据类型:观察性研究。
- 局限:作者指出需进一步研究(further research is warranted)。
对床旁实践的改变
- 作者认为低分辨率低采样LPRx在PRx不可行时可作为其临床预后价值的替代,且可独立于ICP监测方法实施。
- 作者指出该结论需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Moderate-to-severe traumatic brain injury (TBI) has a global mortality rate of about 30%, resulting in acquired life-long disabilities in many survivors. To potentially improve outcomes in this TBI population, the management of secondary injuries, particularly the failure of cerebrovascular reactivity (assessed via the pressure reactivity index; PRx, a correlation between intracranial pressure (ICP) and mean arterial blood pressure (MAP)), has gained interest in the field. However, derivation of PRx requires high-resolution data and expensive technological solutions, as calculations use a short time-window, which has resulted in it being used in only a handful of centers worldwide. As a solution to this, low resolution (longer time-windows) PRx has been suggested, known as Long-PRx or LPRx. Though LPRx has been proposed little is known about the best methodology to derive this measure, with different thresholds and time-windows proposed. Furthermore, the impact of ICP monitoring on cerebrovascular reactivity measures is poorly understood. Hence, this observational study establishes critical thresholds of LPRx associated with long-term functional outcome, comparing different time-windows for calculating LPRx as well as evaluating LPRx determined through external ventricular drains (EVD) vs intraparenchymal pressure device (IPD) ICP monitoring.
METHODS: The study included a total of n = 435 TBI patients from the Karolinska University Hospital. Patients were dichotomized into alive vs. dead and favorable vs. unfavorable outcomes based on 1-year Glasgow Outcome Scale (GOS). Pearson's chi-square values were computed for incrementally increasing LPRx or ICP thresholds against outcome. The thresholds that generated the greatest chi-squared value for each LPRx or ICP parameter had the highest outcome discriminatory capacity. This methodology was also completed for the segmentation of the population based on EVD, IPD, and time of data recorded in hospital stay.
RESULTS: LPRx calculated with 10-120-min windows behaved similarly, with maximal chi-square values ranging at around a LPRx of 0.25-0.35, for both survival and favorable outcome. When investigating the temporal relations of LPRx derived thresholds, the first 4 days appeared to be the most associated with outcomes. The segmentation of the data based on intracranial monitoring found limited differences between EVD and IPD, with similar LPRx values around 0.3.
CONCLUSION: Our work suggests that the underlying prognostic factors causing impairment in cerebrovascular reactivity can, to some degree, be detected using lower resolution PRx metrics (similar found thresholding values) with LPRx found clinically using as low as 10 min-by-minute samples of MAP and ICP. Furthermore, EVD derived LPRx with intermittent cerebrospinal fluid draining, seems to present similar outcome capacity as IPD. This low-resolution low sample LPRx method appears to be an adequate substitute for the clinical prognostic value of PRx and may be implemented independent of ICP monitoring method when PRx is not feasible, though further research is warranted.
参考来源
- Hong E, Froese L, Pontén E, et al. Critical thresholds of long-pressure reactivity index and impact of intracranial pressure monitoring methods in traumatic brain injury. Crit Care. 2024. PMID: 39075480. doi:10.1186/s13054-024-05042-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。